Hot Drug Prospects Drive Impax Higher
You’d think that a company losing its biggest-selling product to competitors would see its stock price plummet. Not generic-drug maker Impax Laboratories (NMS:IPXL).
Read more on Investor’s Business Daily via Yahoo! News
